Learn about Huateng's latest developments, industry news, and research findings
At HT Biosciences, our In Vitro Platform empowers researchers with cutting-edge cell-based technologies to streamline drug discovery, biomarker validation, and therapeutic development. From primary cell isolation to advanced gene editing, our GLP-compliant workflows deliver reliable, reproducible data to advance your projects from bench to bedside.
At HT Biosciences, our Behavioral Neuroscience Platform offers comprehensive, standardized testing to evaluate rodent behavior across motor, cognitive, emotional, and social domains. Utilizing validated paradigms and automated tracking systems, we deliver precise, reproducible data for preclinical studies in CNS drug development, neuropsychiatric research, and neurodegenerative disease modeling.
At HT Biosciences, our Molecular Biology Testing Platform delivers end-to-end solutions for nucleic acid, protein, and biomarker analysis. Leveraging cutting-edge technologies and GLP-compliant workflows, we provide pharmaceutical, biotech, and academic partners with reliable, high-throughput data to advance drug discovery, diagnostic development, and translational research.
At HT Biosciences, our Quantitative Analysis Platform delivers end-to-end solutions for preclinical drug development, combining cutting-edge technologies with GLP-compliant workflows. We provide pharmaceutical, biotech, and academic partners with high-sensitivity, reproducible data to support pharmacokinetic (PK), pharmacodynamic (PD), and toxicology studies, ensuring robust insights from lead optimization to regulatory submissions.
At HT Biosciences, our Histopathology Platform offers end-to-end solutions for tissue processing, staining, and advanced imaging. Combining cutting-edge technologies with GLP-compliant workflows, we deliver high-resolution morphological and molecular insights to accelerate drug development, validate medical devices, and advance disease modeling.
At HT Biosciences, our Biofluids & Tissue Profiling Platform provides comprehensive, GLP-compliant testing services for blood, urine, and tissue samples from experimental animals. Designed for drug developers, medical device innovators, and academic researchers, we deliver reliable, high-throughput data to advance pharmacokinetic studies, toxicity assessments, and disease model validation.
At HT Biosciences, we specialize in designing and validating 200+ standardized and custom animal disease models across species including non-human primates (NHPs), pigs, dogs, rabbits, and rodents. Our platform integrates surgical, chemical, genetic, and dietary induction methods to replicate human disease pathophysiology, enabling precise efficacy and safety evaluations for pharmaceuticals, biologics, and medical devices.
At HT Biosciences, our Advanced Surgical Platforms enable world-class preclinical research through ethically conducted, GLP-compliant animal surgeries. Designed for species ranging from rodents to large animals (pigs, dogs, rabbits, and non-human primates), our facilities and expertise support the creation of robust disease models for drug efficacy evaluation and medical device testing, ensuring your innovations meet global regulatory standards.
At HT Biosciences, our Advanced Imaging Platform integrates cutting-edge technologies to deliver high-resolution, real-time insights into disease mechanisms, therapeutic efficacy, and anatomical dynamics. Designed for preclinical research, our imaging services empower pharmaceutical, biotech, and academic partners to visualize, analyze, and validate discoveries with unmatched clarity and accuracy.